Xue LP - Search Results

1

A stepwise integrated strategy to explore quality markers of Qishen Yiqi dripping pills against myocardial ischemia.

Liu LW, Tang M, Zhang ZB, Zhou PP, Xue LP, Jia QQ, Zhao LG, Zuo LH, Sun Z. Liu LW, et al. Among authors: xue lp. Phytomedicine. 2024 Oct 28;135:156182. doi: 10.1016/j.phymed.2024.156182. Online ahead of print. Phytomedicine. 2024. PMID: 39488103

2

0.05% atropine on control of myopia progression in Chinese school children: a randomized 3-year clinical trial.

Zhu Q, Tang GY, Hua ZJ, Xue LP, Zhou Y, Zhang JY, Zhu YT, Zhang XF. Zhu Q, et al. Among authors: xue lp. Int J Ophthalmol. 2023 Jun 18;16(6):939-946. doi: 10.18240/ijo.2023.06.17. eCollection 2023. Int J Ophthalmol. 2023. PMID: 37332542 Free PMC article.

3

Phenothiazine-Based LSD1 Inhibitor Promotes T-Cell Killing Response of Gastric Cancer Cells.

Dai XJ, Zhao LJ, Yang LH, Guo T, Xue LP, Ren HM, Yin ZL, Xiong XP, Zhou Y, Ji SK, Liu HM, Liu HM, Liu Y, Zheng YC. Dai XJ, et al. Among authors: xue lp. J Med Chem. 2023 Mar 23;66(6):3896-3916. doi: 10.1021/acs.jmedchem.2c01593. Epub 2023 Mar 1. J Med Chem. 2023. PMID: 36856685

4

Triazole-fused pyrimidines in target-based anticancer drug discovery.

Dai XJ, Xue LP, Ji SK, Zhou Y, Gao Y, Zheng YC, Liu HM, Liu HM. Dai XJ, et al. Among authors: xue lp. Eur J Med Chem. 2023 Mar 5;249:115101. doi: 10.1016/j.ejmech.2023.115101. Epub 2023 Jan 11. Eur J Med Chem. 2023. PMID: 36724635 Review.

5

COVID-19 infection with keratitis as the first clinical manifestation.

Zuo DM, Xue LP, Fan H, Yang SL, Li LC, Luo JH, Zang S, Xiao J. Zuo DM, et al. Among authors: xue lp. Int J Ophthalmol. 2022 Sep 18;15(9):1544-1548. doi: 10.18240/ijo.2022.09.19. eCollection 2022. Int J Ophthalmol. 2022. PMID: 36124194 Free PMC article.

6

Correction to "Reversible Lysine Specific Demethylase 1 (LSD1) Inhibitors: A Promising Wrench to Impair LSD1".

Dai XJ, Liu Y, Xue LP, Xiong XP, Zhou Y, Zheng YC, Liu HM. Dai XJ, et al. Among authors: xue lp. J Med Chem. 2021 May 13;64(9):6410-6411. doi: 10.1021/acs.jmedchem.1c00568. Epub 2021 Apr 19. J Med Chem. 2021. PMID: 33871995 No abstract available.

7

Correction to "Tranylcypromine Based Lysine-Specific Demethylase 1 Inhibitor: Summary and Perspective".

Dai XJ, Liu Y, Xiong XP, Xue LP, Zheng YC, Liu HM. Dai XJ, et al. Among authors: xue lp. J Med Chem. 2021 May 13;64(9):6412. doi: 10.1021/acs.jmedchem.1c00570. Epub 2021 Apr 19. J Med Chem. 2021. PMID: 33871987 No abstract available.

8

Reversible Lysine Specific Demethylase 1 (LSD1) Inhibitors: A Promising Wrench to Impair LSD1.

Dai XJ, Liu Y, Xue LP, Xiong XP, Zhou Y, Zheng YC, Liu HM. Dai XJ, et al. Among authors: xue lp. J Med Chem. 2021 Mar 11;64(5):2466-2488. doi: 10.1021/acs.jmedchem.0c02176. Epub 2021 Feb 23. J Med Chem. 2021. PMID: 33619958 Review.

9

Tranylcypromine Based Lysine-Specific Demethylase 1 Inhibitor: Summary and Perspective.

Dai XJ, Liu Y, Xiong XP, Xue LP, Zheng YC, Liu HM. Dai XJ, et al. Among authors: xue lp. J Med Chem. 2020 Dec 10;63(23):14197-14215. doi: 10.1021/acs.jmedchem.0c00919. Epub 2020 Sep 30. J Med Chem. 2020. PMID: 32931269 Review.

10

[Clinical featuers of adult patients with post-viral-encephalitis autoimmune encephalitis].

Fu ZY, Ren HT, Xue LP, Tian YN, Fan SY, Zhao YH, Lin N, Yin HX, Jiang N, Peng B, Cui LY, Guan HZ. Fu ZY, et al. Among authors: xue lp. Zhonghua Yi Xue Za Zhi. 2020 Jul 7;100(25):1933-1936. doi: 10.3760/cma.j.cn112137-20200115-00095. Zhonghua Yi Xue Za Zhi. 2020. PMID: 32629591 Chinese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

23 results

Search Page

Filters